Acute Haematogenous Osteomyelitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acute Haematogenous Osteomyelitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (4 shown)

CompletedNot Applicable

NCT03846804

Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections

The purpose of this study is to evaluate the use of a blood test: Karius® plasma-based next-generation sequencing test (Karius Test), to see if we can detect an…

United States38 participantsStarted 2019-09-01

Treatment: Karius Test

CompletedNot Applicable

NCT03827980

Long- and Midterm Outcomes of Osteoarticular Infections in Paediatric Patients

Multi-centre clinical follow-up study on patients with a history of acute haematogenous osteomyelitis and/or septic arthritis. The aim is to describe the freque…

Switzerland78 participantsStarted 2019-02-08

Treatment: no intervention, only clinical examination

CompletedPhase 3

NCT01922011

Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous…

The purpose of the study is to determine whether daptomycin is effective and safe in the treatment of pediatric participants with AHO when compared to vancomyci…

Location not specified149 participantsStarted 2013-09-13

Treatment: Daptomycin, Vancomycin (or equivalent)

WithdrawnPhase 3

NCT02344511

Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis

Dalbavancin for Pediatric Osteomyelitis

Location not specified0Started 2016-03

Treatment: Dalbavancin, cefazolin, nafcillin, oxacillin or vancomycin